Relationship between adipocytokines and cardiovascular risk factors in patients with type 2 diabetes mellitus

被引:84
作者
Uslu, Sema [1 ]
Kebapci, Nur [2 ]
Kara, Mehmet [1 ]
Bal, Cengiz [3 ]
机构
[1] Eskisehir Osmangazi Univ, Sch Med, Dept Med Biochem, TR-26480 Eskisehir, Turkey
[2] Eskisehir Osmangazi Univ, Sch Med, Dept Endocrinol, TR-26480 Eskisehir, Turkey
[3] Eskisehir Osmangazi Univ, Sch Med, Dept Biostat, TR-26480 Eskisehir, Turkey
关键词
adipocytokines; cardiovascular risk markers; type 2 diabetes mellitus; INSULIN-RESISTANCE; ASYMMETRIC DIMETHYLARGININE; HOMOCYSTEINE LEVELS; METABOLIC SYNDROME; ADIPONECTIN LEVELS; JAPANESE PATIENTS; OXIDATIVE STRESS; SERUM VISFATIN; LEPTIN; DISEASE;
D O I
10.3892/etm.2012.557
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The aim of this study was to explore the relationship between serum profiles of adiponectin, leptin, resistin and visfatin and traditional and non-traditional cardiovascular risk factors in patients with type 2 diabetes mellitus (T2DM). A total of 85 patients with T2DM and 30 non-diabetic controls were enrolled in the study. Levels of adipocytokines (adiponectin, leptin, resistin and visfatin), lipids (total cholesterol, triglycerides), lipoproteins [HDL-cholesterol, LDL-cholesterol, lipoprotein (a)], apolipoproteins (Apo-A1 and Apo-B), non-traditional cardiovascular risk markers [asymmetric dimethylarginine (ADMA), homocysteine] and the inflammatory marker hs-CRP were measured, and anthropometric variables were determined. Serum adiponectin levels were decreased and leptin, resistin and visfatin levels were increased in T2DM patients compared to controls. They were associated with obesity (BM I), insulin resistance (HOMA-IR) and various markers of glucose/lipid profile, inflammation and endothelial dysfunction markers. These results suggest that decreased serum adiponectin and increased leptin, resistin and visfatin levels in T2DM may be novel biochemical risk factors for cardiovascular complications.
引用
收藏
页码:113 / 120
页数:8
相关论文
共 50 条
[1]   Plasma leptin concentration in patients with Type 2 diabetes: relationship to cardiovascular disease risk factors and insulin resistance [J].
Abdella, NA ;
Mojiminiyi, OA ;
Moussa, MA ;
Zaki, M ;
Al Mohammedi, H ;
Al Ozairi, ESS ;
Al Jebely, S .
DIABETIC MEDICINE, 2005, 22 (03) :278-285
[2]   Relation of plasma homocysteine levels to atherosclerotic vascular disease and inflammation markers in type 2 diabetic patients [J].
Akalin, Aysen ;
Alatas, Ozkan ;
Colak, Omer .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2008, 158 (01) :47-52
[3]   Serum resistin is associated with C-reactive protein and LDL- cholesterol in type 2 diabetes and coronary artery disease in a Saudi population [J].
Al-Daghri, N. ;
Chetty, R. ;
McTernan, P. G. ;
Al-Rubean, K. ;
Al-Attas, O. ;
Jones, A. F. ;
Kumar, S. .
CARDIOVASCULAR DIABETOLOGY, 2005, 4 (1)
[4]  
Alghasham AA, 2008, SAUDI MED J, V29, P185
[5]   Relationship of leptin level with metabolic disorders and hypertension in Japanese type 2 diabetes mellitus patients [J].
Asakawa, H ;
Tokunaga, K ;
Kawakami, F .
JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2001, 15 (02) :57-62
[6]   Endothelial dysfunction and diabetes: roles of hyperglycemia, impaired insulin signaling and obesity [J].
Bakker, Wineke ;
Eringa, Etto C. ;
Sipkema, Pieter ;
van Hinsbergh, Victor W. M. .
CELL AND TISSUE RESEARCH, 2009, 335 (01) :165-189
[7]  
Bartels DW, 2007, J MANAGE CARE PHAR S, V13, pS2
[8]   Visfatin in overweight/obesity, type 2 diabetes mellitus, insulin resistance, metabolic syndrome and cardiovascular diseases: a meta-analysis and systemic review [J].
Chang, Yu-Hung ;
Chang, Dao-Ming ;
Lin, Kun-Cheng ;
Shin, Shyi-Jang ;
Lee, Yau-Jiunn .
DIABETES-METABOLISM RESEARCH AND REVIEWS, 2011, 27 (06) :515-527
[9]   Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus [J].
Chen, MP ;
Chung, FM ;
Chang, DM ;
Tsai, JCR ;
Huang, HF ;
Shin, SJ ;
Lee, YJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (01) :295-299
[10]   Relation of resistin levels with cardiovascular risk factors, insulin resistance and inflammation in naive diabetes obese patients [J].
de Luis, D. A. ;
Gonzalez Sagrado, M. ;
Conde, R. ;
Aller, R. ;
Izaola, O. ;
de la Fuente, B. ;
Castrillon, J. L. Perez ;
Romero, E. .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2010, 89 (02) :110-114